Skip to main content
Caplight Logo









Castor

Castor

Private
AmsterdamHealthcare & Life Scienceshttps://www.castoredc.com/

Last Round

Series B

Jul 14, 2021

Est. Valuation

$250M

Total Funding Raised

$64.48M

Company Overview

Castor is a health-tech company that provides a cloud-based clinical data platform to simplify the clinical trial process for researchers worldwide.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement, Data Integration

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

EDCelectronic data captureclinical trial softwareeCRFeClinicalclinical data managementePROclinical research platformpatient engagementeCOACDISC mappingeConsentclinical trial automationvertical SaaShealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Castor Comparables

Compare Castor with similar companies based on industry and business-model similarity.

Castor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medrio
90%
Viedoc
90%
nPhase, Inc.
86%

Castor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 14, 2021
Series AAug 19, 2020
SeedJul 2, 2018
GrantMay 23, 2017

Key People

Founding team and executive leadership

Derk Arts

Founder & CEO

Founding Team

Solange M.

Manager Of CEO Operations

Executive Team

Andrew Sadler

Chief Technology Officer

Executive Team

Tobias Schaefer

Chief Financial Officer

Executive Team

Castor Investors

Notable investors and investment history

Castor investors
InvestorRounds
European CommissionGrant
F-Prime CapitalSeries B
Eight Roads VenturesSeries B
Two Sigma VenturesSeries B, Series A
F-Prime CapitalSeries B
Inkef CapitalSeries A, Series B, Seed
WR Hambrecht + CoSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Partnering with Stefanini for phone support and device provisioning.

  • Jan 21, 2026

    Job posting reveals tooling support partnership with Zendesk.

Castor Filings

Explore SEC and related filing metadata, where available.

Castor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Castor's valuation, stock price, and market status.

Is Castor a public or private company?

Castor is a private company.

What is the current stock price of Castor?

Castor is a private company with no public stock price. No recent secondary market data is available.

How much is Castor worth (valuation)?

Valuation information for Castor is not publicly available.

Can I buy Castor stock?

Castor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Castor's last funding round?

Castor's most recent funding round was Series B on July 14, 2021.

Who are the main investors in Castor?

Key investors in Castor include F-Prime Capital, Eight Roads Ventures, Two Sigma Ventures, Inkef Capital.

Will Castor IPO soon?

No public IPO plans have been announced for Castor.

How can I track Castor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Castor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range310
Year Founded2012
Last FundingJul 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?